{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:22:46Z","timestamp":1781299366819,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01435-2","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:21:02Z","timestamp":1737264062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Computational frameworks transform antagonism to synergy in optimizing combination therapies"],"prefix":"10.1038","volume":"8","author":[{"given":"Jinghong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuofeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia, J. et al. Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111\u2013128 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1435_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"T-C Chou","year":"2006","unstructured":"Chou, T.-C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621\u2013681 (2006).","journal-title":"Pharmacol. Rev."},{"key":"1435_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.282.5389.682","volume":"282","author":"FS Collins","year":"1998","unstructured":"Collins, F. S. et al. New goals for the US human genome project: 1998-2003. Science 282, 682\u2013689 (1998).","journal-title":"Science"},{"key":"1435_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrg1809","volume":"7","author":"JD Hoheisel","year":"2006","unstructured":"Hoheisel, J. D. Microarray technology: beyond transcript profiling and genotype analysis. Nat. Rev. Genet. 7, 200\u2013210 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"1435_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/nbt.2877","volume":"32","author":"JC Costello","year":"2014","unstructured":"Costello, J. C. et al. A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol. 32, 1202\u20131212 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1435_CR6","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2018","unstructured":"Preuer, K. et al. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning. Bioinformatics 34, 1538\u20131546 (2018).","journal-title":"Bioinformatics"},{"key":"1435_CR7","doi-asserted-by":"publisher","first-page":"i228","DOI":"10.1093\/bioinformatics\/btu278","volume":"30","author":"L Huang","year":"2014","unstructured":"Huang, L. et al. DrugComboRanker: drug combination discovery based on target network analysis. Bioinformatics 30, i228\u2013i236 (2014).","journal-title":"Bioinformatics"},{"key":"1435_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.drudis.2015.09.003","volume":"21","author":"KC Bulusu","year":"2016","unstructured":"Bulusu, K. C. et al. Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives. Drug Discov. Today 21, 225\u2013238 (2016).","journal-title":"Drug Discov. Today"},{"key":"1435_CR9","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1136\/amiajnl-2013-002512","volume":"21","author":"F Cheng","year":"2014","unstructured":"Cheng, F. & Zhao, Z. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. J. Am. Med. Inf. Assoc. 21, e278\u2013e286 (2014).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bib\/bbw104","volume":"19","author":"SA Madani Tonekaboni","year":"2018","unstructured":"Madani Tonekaboni, S. A., Soltan Ghoraie, L., Manem, V. S. K. & Haibe-Kains, B. Predictive approaches for drug combination discovery in cancer. Brief Bioinform. 19, 263\u2013276 (2018).","journal-title":"Brief Bioinform."},{"key":"1435_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702.e613 (2020).","journal-title":"Cell"},{"key":"1435_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nbt.3052","volume":"32","author":"M Bansal","year":"2014","unstructured":"Bansal, M. et al. A community computational challenge to predict the activity of pairs of compounds. Nat. Biotechnol. 32, 1213\u20131222 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1435_CR14","doi-asserted-by":"crossref","unstructured":"Zhang, T., Zhang, L., Payne, P. R. & Li, F. Synergistic drug combination prediction by integrating multiomics data in deep learning models. Translational Bioinformatics for Therapeutic Development, 223\u2013238 (2021).","DOI":"10.1007\/978-1-0716-0849-4_12"},{"key":"1435_CR15","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1093\/bioinformatics\/btz109","volume":"35","author":"L Huang","year":"2019","unstructured":"Huang, L. et al. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction. Bioinformatics 35, 3709\u20133717 (2019).","journal-title":"Bioinformatics"},{"key":"1435_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"CI Bliss","year":"1939","unstructured":"Bliss, C. I. The toxicity of poisons applied jointly 1. Ann. Appl. Biol. 26, 585\u2013615 (1939).","journal-title":"Ann. Appl. Biol."},{"key":"1435_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou, T.-C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzym. Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzym. Regul."},{"key":"1435_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41588-018-0160-6","volume":"50","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat. Genet. 50, 1171\u20131179 (2018).","journal-title":"Nat. Genet."},{"key":"1435_CR19","doi-asserted-by":"publisher","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","volume":"34","author":"M Zitnik","year":"2018","unstructured":"Zitnik, M., Agrawal, M. & Leskovec, J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics 34, i457\u2013i466 (2018).","journal-title":"Bioinformatics"},{"key":"1435_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cels.2015.10.003","volume":"1","author":"A Bordbar","year":"2015","unstructured":"Bordbar, A. et al. Personalized whole-cell kinetic models of metabolism for discovery in genomics and pharmacodynamics. Cell Syst. 1, 283\u2013292 (2015).","journal-title":"Cell Syst."},{"key":"1435_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/npjsba.2016.13","volume":"2","author":"MB Guebila","year":"2016","unstructured":"Guebila, M. B. & Thiele, I. Model-based dietary optimization for late-stage, levodopa-treated, Parkinson\u2019s disease patients. NPJ Syst. Biol. Appl. 2, 16013 (2016).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ymben.2016.10.022","volume":"43","author":"A Nilsson","year":"2017","unstructured":"Nilsson, A. & Nielsen, J. Genome scale metabolic modeling of cancer. Metab. Eng. 43, 103\u2013112 (2017).","journal-title":"Metab. Eng."},{"key":"1435_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"1435_CR24","doi-asserted-by":"publisher","first-page":"D876","DOI":"10.1093\/nar\/gkr1011","volume":"40","author":"M Kuhn","year":"2012","unstructured":"Kuhn, M. et al. STITCH 3: zooming in on protein\u2013chemical interactions. Nucleic Acids Res. 40, D876\u2013D880 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"D535","DOI":"10.1093\/nar\/gkj109","volume":"34","author":"C Stark","year":"2006","unstructured":"Stark, C. et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535\u2013D539 (2006).","journal-title":"Nucleic Acids Res."},{"key":"1435_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","volume":"47","author":"SJ Rigatti","year":"2017","unstructured":"Rigatti, S. J. Random forest. J. Insur. Med. 47, 31\u201339 (2017).","journal-title":"J. Insur. Med."},{"key":"1435_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B: Stat. Methodol. 67, 301\u2013320 (2005).","journal-title":"J. R. Stat. Soc. Ser. B: Stat. Methodol."},{"key":"1435_CR28","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1093\/bioinformatics\/bty156","volume":"34","author":"PL Cedoz","year":"2018","unstructured":"Cedoz, P. L., Prunello, M., Brennan, K. & Gevaert, O. MethylMix 2.0: an R package for identifying DNA methylation genes. Bioinformatics 34, 3044\u20133046 (2018).","journal-title":"Bioinformatics"},{"key":"1435_CR29","doi-asserted-by":"publisher","first-page":"e42573","DOI":"10.1371\/journal.pone.0042573","volume":"7","author":"JH Lee","year":"2012","unstructured":"Lee, J. H. et al. CDA: combinatorial drug discovery using transcriptional response modules. PLoS One 7, e42573 (2012).","journal-title":"PLoS One"},{"key":"1435_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.artmed.2017.05.008","volume":"83","author":"X Li","year":"2017","unstructured":"Li, X. et al. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles. Artif. Intell. Med. 83, 35\u201343 (2017).","journal-title":"Artif. Intell. Med."},{"key":"1435_CR31","first-page":"241","volume":"2","author":"L Zhao","year":"2010","unstructured":"Zhao, L., Au, J. L.-S. & Wientjes, M. G. Comparison of methods for evaluating drug-drug interaction. Front. Biosci. (Elite Ed.) 2, 241 (2010).","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"1435_CR32","doi-asserted-by":"publisher","unstructured":"Sun, X., Vilar, S. & Tatonetti, N. P. High-throughput methods for combinatorial drug discovery. Sci. Transl. Med. 5, 205rv201-205rv201 https:\/\/doi.org\/10.1126\/scitranslmed.3006667 (2013).","DOI":"10.1126\/scitranslmed.3006667"},{"key":"1435_CR33","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/bioinformatics\/btv080","volume":"31","author":"P Li","year":"2015","unstructured":"Li, P. et al. Large-scale exploration and analysis of drug combinations. Bioinformatics 31, 2007\u20132016 (2015).","journal-title":"Bioinformatics"},{"key":"1435_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrg.2016.69","volume":"17","author":"J Saez-Rodriguez","year":"2016","unstructured":"Saez-Rodriguez, J. et al. Crowdsourcing biomedical research: leveraging communities as innovation engines. Nat. Rev. Genet. 17, 470\u2013486 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1435_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1407.021","volume":"1115","author":"G Stolovitzky","year":"2007","unstructured":"Stolovitzky, G., Monroe, D. & Califano, A. Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference. Ann. N.Y. Acad. Sci. 1115, 1\u201322 (2007).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"1435_CR36","doi-asserted-by":"publisher","first-page":"e68598","DOI":"10.1371\/journal.pone.0068598","volume":"8","author":"P Gerlee","year":"2013","unstructured":"Gerlee, P. et al. Searching for synergies: matrix algebraic approaches for efficient pair screening. PLoS One 8, e68598 (2013).","journal-title":"PLoS One"},{"key":"1435_CR37","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein-protein interaction network. Brief Bioinform. 23, https:\/\/doi.org\/10.1093\/bib\/bbab587 (2022).","DOI":"10.1093\/bib\/bbab587"},{"key":"1435_CR38","doi-asserted-by":"publisher","unstructured":"Gan, Y., Huang, X., Guo, W., Yan, C. & Zou, G. Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor. Bioinformatics 39, https:\/\/doi.org\/10.1093\/bioinformatics\/btad607 (2023).","DOI":"10.1093\/bioinformatics\/btad607"},{"key":"1435_CR39","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkab438","volume":"49","author":"S Zheng","year":"2021","unstructured":"Zheng, S. et al. DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal. Nucleic Acids Res. 49, W174\u2013W184 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1435_CR40","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945\u2013D954 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1435_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","volume":"580","author":"K Luck","year":"2020","unstructured":"Luck, K. et al. A reference map of the human binary protein interactome. Nature 580, 402\u2013408 (2020).","journal-title":"Nature"},{"key":"1435_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the cancer cell line encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"1435_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep36812","volume":"6","author":"TA Knijnenburg","year":"2016","unstructured":"Knijnenburg, T. A. et al. Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy. Sci. Rep. 6, 36812 (2016).","journal-title":"Sci. Rep."},{"key":"1435_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-cancerbio-042016-073434","volume":"1","author":"RL Beijersbergen","year":"2017","unstructured":"Beijersbergen, R. L., Wessels, L. F. & Bernards, R. Synthetic lethality in cancer therapeutics. Annu. Rev. Cancer Biol. 1, 141\u2013161 (2017).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"1435_CR45","first-page":"2211","volume":"12","author":"M G\u00f6nen","year":"2011","unstructured":"G\u00f6nen, M. & Alpayd\u0131n, E. Multiple kernel learning algorithms. J. Mach. Learn. Res. 12, 2211\u20132268 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"1435_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12551-018-0446-z","volume":"11","author":"M Ali","year":"2019","unstructured":"Ali, M. & Aittokallio, T. Machine learning and feature selection for drug response prediction in precision oncology applications. Biophys. Rev. 11, 31\u201339 (2019).","journal-title":"Biophys. Rev."},{"key":"1435_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0460-9","volume":"12","author":"YC Chiu","year":"2019","unstructured":"Chiu, Y. C. et al. Predicting drug response of tumors from integrated genomic profiles by deep neural networks. BMC Med. Genom. 12, 18 (2019).","journal-title":"BMC Med. Genom."},{"key":"1435_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep31619","volume":"6","author":"H Yuan","year":"2016","unstructured":"Yuan, H., Paskov, I., Paskov, H., Gonzalez, A. J. & Leslie, C. S. Multitask learning improves prediction of cancer drug sensitivity. Sci. Rep. 6, 31619 (2016).","journal-title":"Sci. Rep."},{"key":"1435_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45236-6","volume":"9","author":"R Celebi","year":"2019","unstructured":"Celebi, R., Bear Don\u2019t Walk, O. T., Movva, R., Alpsoy, S. & Dumontier, M. In-silico prediction of synergistic anti-cancer drug combinations using multi-omics data. Sci. Rep. 9, 8949 (2019).","journal-title":"Sci. Rep."},{"key":"1435_CR50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/bioinformatics\/bty637","volume":"35","author":"A Valdeolivas","year":"2018","unstructured":"Valdeolivas, A. et al. Random walk with restart on multiplex and heterogeneous biological networks. Bioinformatics 35, 497\u2013505 (2018).","journal-title":"Bioinformatics"},{"key":"1435_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biosystems.2004.10.002","volume":"80","author":"RP Araujo","year":"2005","unstructured":"Araujo, R. P., Petricoin, E. F. & Liotta, L. A. A mathematical model of combination therapy using the EGFR signaling network. Biosystems 80, 57\u201369 (2005).","journal-title":"Biosystems"},{"key":"1435_CR52","doi-asserted-by":"publisher","first-page":"e93960","DOI":"10.1371\/journal.pone.0093960","volume":"9","author":"N Yin","year":"2014","unstructured":"Yin, N. et al. Synergistic and antagonistic drug combinations depend on network topology. PLoS One 9, e93960 (2014).","journal-title":"PLoS One"},{"key":"1435_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1435_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"1435_CR55","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","volume":"8","author":"RA Burrell","year":"2014","unstructured":"Burrell, R. A. & Swanton, C. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol. Oncol. 8, 1095\u20131111 (2014).","journal-title":"Mol. Oncol."},{"key":"1435_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9836256","volume":"2018","author":"S Chakraborty","year":"2018","unstructured":"Chakraborty, S., Hosen, M. I., Ahmed, M. & Shekhar, H. U. Onco-multi-OMICS approach: a new frontier in cancer research. Biomed. Res. Int. 2018, 9836256 (2018).","journal-title":"Biomed. Res. Int."},{"key":"1435_CR57","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182, 1232\u20131251 e1222 (2020).","journal-title":"Cell"},{"key":"1435_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts, H. J. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 4006 (2014).","journal-title":"Nat. Commun."},{"key":"1435_CR59","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"1435_CR60","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1435_CR61","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","volume":"23","author":"D Senft","year":"2017","unstructured":"Senft, D., Leiserson, M. D. M., Ruppin, E. & Ronai, Ze. A. Precision oncology: the road ahead. Trends Mol. Med. 23, 874\u2013898 (2017).","journal-title":"Trends Mol. Med."},{"key":"1435_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/019262339502300203","volume":"23","author":"LZ Benet","year":"1995","unstructured":"Benet, L. Z. & Zia-Amirhosseini, P. Basic principles of pharmacokinetics. Toxicol. Pathol. 23, 115\u2013123 (1995).","journal-title":"Toxicol. Pathol."},{"key":"1435_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","volume":"3","author":"I Kola","year":"2004","unstructured":"Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711\u2013716 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1435_CR64","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak, I. W., Evaniew, N. & Ghert, M. Lost in translation: animal models and clinical trials in cancer treatment. Am. J. Transl. Res. 6, 114 (2014).","journal-title":"Am. J. Transl. Res."},{"key":"1435_CR65","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/jps.23614","volume":"102","author":"T Bohnert","year":"2013","unstructured":"Bohnert, T. & Gan, L. S. Plasma protein binding: from discovery to development. J. Pharm. Sci. 102, 2953\u20132994 (2013).","journal-title":"J. Pharm. Sci."},{"key":"1435_CR66","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.drudis.2012.03.015","volume":"17","author":"L Di","year":"2012","unstructured":"Di, L. et al. Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. Drug Discov. Today 17, 905\u2013912 (2012).","journal-title":"Drug Discov. Today"},{"key":"1435_CR67","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic, M. M., Struys, M. M. & Absalom, A. R. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin. Pharmacokinet.57, 1539\u20131558 (2018).","journal-title":"Clin. Pharmacokinet."},{"key":"1435_CR68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 64, 4\u201317 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1435_CR69","doi-asserted-by":"crossref","unstructured":"International Transporter, C. et al. Membrane transporters in drug development. Nat Rev Drug Discov 9, 215\u2013236 (2010).","DOI":"10.1038\/nrd3028"},{"key":"1435_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton, A. I. & Tannock, I. F. Drug penetration in solid tumours. Nat. Rev. Cancer 6, 583\u2013592 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1435_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","volume":"51","author":"M Rowland","year":"2011","unstructured":"Rowland, M., Peck, C. & Tucker, G. Physiologically-based pharmacokinetics in drug development and regulatory science. Annu. Rev. Pharmacol. Toxicol. 51, 45\u201373 (2011).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1435_CR72","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrd4591","volume":"14","author":"KM Mahoney","year":"2015","unstructured":"Mahoney, K. M., Rennert, P. D. & Freeman, G. J. Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14, 561\u2013584 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1435_CR73","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40259-016-0204-3","volume":"30","author":"D Day","year":"2016","unstructured":"Day, D. & Hansen, A. R. Immune-related adverse events associated with immune checkpoint inhibitors. BioDrugs 30, 571\u2013584 (2016).","journal-title":"BioDrugs"},{"key":"1435_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0553-9","volume":"7","author":"T Courau","year":"2019","unstructured":"Courau, T. et al. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment. J. Immunother. Cancer 7, 1\u201314 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1435_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00811-2","volume":"8","author":"Y Heshiki","year":"2020","unstructured":"Heshiki, Y. et al. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 8, 28 (2020).","journal-title":"Microbiome"},{"key":"1435_CR76","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander, J. L. et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat. Rev. Gastroenterol. Hepatol. 14, 356\u2013365 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1435_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"1435_CR78","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462\u2013467 (2019).","journal-title":"Nature"},{"key":"1435_CR79","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156\u20131160 (2017).","journal-title":"Science"},{"key":"1435_CR80","doi-asserted-by":"publisher","first-page":"e1004977","DOI":"10.1371\/journal.pcbi.1004977","volume":"12","author":"E Pasolli","year":"2016","unstructured":"Pasolli, E., Truong, D. T., Malik, F., Waldron, L. & Segata, N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol. 12, e1004977 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"1435_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","volume":"22","author":"MJ Alomar","year":"2014","unstructured":"Alomar, M. J. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm. J. 22, 83\u201394 (2014).","journal-title":"Saudi Pharm. J."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01435-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01435-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01435-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T17:14:23Z","timestamp":1737306863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01435-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01435-2","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}